ATE377944T1 - Methode für die behandlung einer hepatitisvirusinfektion - Google Patents

Methode für die behandlung einer hepatitisvirusinfektion

Info

Publication number
ATE377944T1
ATE377944T1 AT96936025T AT96936025T ATE377944T1 AT E377944 T1 ATE377944 T1 AT E377944T1 AT 96936025 T AT96936025 T AT 96936025T AT 96936025 T AT96936025 T AT 96936025T AT E377944 T1 ATE377944 T1 AT E377944T1
Authority
AT
Austria
Prior art keywords
virus infection
treating hepatitis
hepatitis virus
hepatitis
methods
Prior art date
Application number
AT96936025T
Other languages
English (en)
Inventor
Hiroshi Takahashi
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Application granted granted Critical
Publication of ATE377944T1 publication Critical patent/ATE377944T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804—Nucleic acid analysis using immunogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Environmental Sciences (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96936025T 1995-09-27 1996-09-27 Methode für die behandlung einer hepatitisvirusinfektion ATE377944T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US435795P 1995-09-27 1995-09-27

Publications (1)

Publication Number Publication Date
ATE377944T1 true ATE377944T1 (de) 2007-11-15

Family

ID=21710385

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96936025T ATE377944T1 (de) 1995-09-27 1996-09-27 Methode für die behandlung einer hepatitisvirusinfektion

Country Status (6)

Country Link
EP (1) EP0866654B1 (de)
JP (1) JP2000501921A (de)
AT (1) ATE377944T1 (de)
AU (1) AU7377296A (de)
DE (1) DE69637325D1 (de)
WO (1) WO1997011598A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6296844B1 (en) * 1995-09-27 2001-10-02 The General Hospital Corporation Asialocytokines and treatment of liver disease
AU6092900A (en) * 1999-07-14 2001-02-05 Board Of Trustees Of The Leland Stanford Junior University Animals comprising human hepatocellular tissue
EP1327687A4 (de) * 2000-10-03 2004-08-11 Tokyo Metropolitan Org Med Res Verfahren zur infektion des hepatitis c viruses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR950014915B1 (ko) * 1991-06-19 1995-12-18 주식회사녹십자 탈시알로당단백-포함화합물
ATE361975T1 (de) * 1993-05-17 2007-06-15 Yeda Res & Dev Tiermodell für hepatitis-virus infektion
US5378605A (en) * 1993-06-08 1995-01-03 Thomas Jefferson University Method of detecting hepatitis B variants having deletions within the X region of the virus genome

Also Published As

Publication number Publication date
EP0866654A1 (de) 1998-09-30
JP2000501921A (ja) 2000-02-22
AU7377296A (en) 1997-04-17
EP0866654A4 (de) 2002-08-21
WO1997011598A1 (en) 1997-04-03
DE69637325D1 (de) 2007-12-27
EP0866654B1 (de) 2007-11-14

Similar Documents

Publication Publication Date Title
DE3789158D1 (de) Verfahren zur Sterilisation und Vorrichtung dafür.
DE59600309D1 (de) Vorrichtung zur Behandlung von Flüssigkeiten, insbesondere von Blut
DE69112480D1 (de) Verfahren und Vorrichtung zur Behandlung von medizinischen Abfallstoffen.
DE69022163D1 (de) Steriles erzeugnis und verfahren zur sterilisierung und zusammenbau dieses erzeugnisses.
DE3485688D1 (de) Verfahren und vorrichtung zur behandlung von krankheiten.
DE69109422D1 (de) Verbessertes Verfahren und Vorrichtung für Sauerstoffanreicherung.
DE59611451D1 (de) Verfahren und Vorrichtung zur Einsatzoptimierung von Landmaschinen
DE3854111D1 (de) Vorrichtung und verfahren zur behandlung mit plasma.
DE3877773D1 (de) Vorrichtung und verfahren zur impfung von fischen.
DE68923877D1 (de) Verfahren und vorrichtung für die hydroponkultur.
DE3784753D1 (de) Vorrichtung und verfahren zur behandlung stehender gewaesser.
DE3680782D1 (de) Verfahren und vorrichtung zur herstellung von duennwandigen rohren.
ATA226888A (de) Verfahren zur behandlung eines abgasstroms
DE69423164D1 (de) Verfahren und Vorrichtung zur biologischen Aufbereitung von wässerigen organischen Abfällen
DE59009072D1 (de) Verfahren und vorrichtung zur ermittlung von chemischen zuständen von lebendem, tierischem oder menschlichem gewebe unter verwendung von magnetischer resonanz.
DE69107756D1 (de) Vorrichtung und Verfahren zur Evakuierung von Blutentnahmeröhrchen.
DE3860179D1 (de) Verfahren und vorrichtung zur vernichtung von giftigen abgasen.
DE3885761D1 (de) Verfahren, anwendung desselben und vorrichtung zur lambdawerterfassung.
DE69013880D1 (de) Verfahren und Vorrichtung zur Behandlung von Absorptionssuspensionen, die Flugasche beinhalten.
DE3766124D1 (de) Verfahren und vorrichtung zur sprachverarbeitung.
DE3874579D1 (de) Verfahren und vorrichtung zur behandlung von tierischem fleisch, insbesondere von fisch, zum entfaerben und geruchlosmachen.
DE60015791D1 (de) Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
ATE377944T1 (de) Methode für die behandlung einer hepatitisvirusinfektion
DE69517191D1 (de) Wasserlösliche derivate epipodophyllotoxine, verfahren zu ihrer herstellung, ihre verwendung als medikament und ihre verwendung zur herstellung eines antikrebsmittels
DE58904328D1 (de) Verfahren zur desinfektion von medizinischen abformmassen.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties